The co-expression of TIM-3 with PD-1 on tumor-specific CD8+ T cells has also been reported, and dually blocking them considerably improves the in vitro cytokine production and proliferation of human T cells when stimulated via NY-ESO-1 or the cancer-testes antigen. Here, CD8A is linked to neoplasm.